PINNACLE FINANCIAL PARTNERS INC - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 167 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PINNACLE FINANCIAL PARTNERS INC ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$45,990
-20.0%
1,0000.0%0.00%0.0%
Q2 2023$57,470
+53.3%
1,0000.0%0.00%0.0%
Q1 2023$37,500
+33.8%
1,0000.0%0.00%0.0%
Q4 2022$28,020
+0.1%
1,0000.0%0.00%0.0%
Q3 2022$28,000
-20.0%
1,0000.0%0.00%0.0%
Q2 2022$35,000
-2.8%
1,0000.0%0.00%0.0%
Q1 2022$36,000
+56.5%
1,0000.0%0.00%0.0%
Q4 2021$23,000
+21.1%
1,0000.0%0.00%0.0%
Q3 2021$19,000
-5.0%
1,0000.0%0.00%0.0%
Q2 2021$20,0000.0%1,0000.0%0.00%0.0%
Q1 2021$20,000
+5.3%
1,0000.0%0.00%0.0%
Q4 2020$19,0000.0%1,0000.0%0.00%0.0%
Q3 2020$19,000
-13.6%
1,0000.0%0.00%0.0%
Q2 2020$22,000
+46.7%
1,0000.0%0.00%0.0%
Q1 2020$15,000
-21.1%
1,0000.0%0.00%0.0%
Q4 2019$19,000
-5.0%
1,0000.0%0.00%
-50.0%
Q1 2019$20,000
+5.3%
1,0000.0%0.00%0.0%
Q3 2018$19,000
+26.7%
1,0000.0%0.00%
+100.0%
Q2 2018$15,000
-21.1%
1,0000.0%0.00%
-50.0%
Q1 2018$19,0001,0000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q4 2021
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders